Overall, tilianin suppresses NLRP3 inflammasome activation in myocardial ischemia/reperfusion injury by inhibiting the TLR4/NF-κB and NEK7/NLRP3 pathways. The gene discussed is NEK7; the disease is myocardial ischemia.